Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

Description

This project allows for the systematic collection and analysis of long-term follow-up clinical parameters in children who have received a stem cell transplant. The data collected will assist in determining appropriate intervention and treatment plans for patients enrolled on this study. In addition, future patients may benefit by having the ability to anticipate problems and develop methods of prevention or early intervention.

Conditions

Blood and Marrow Transplant (BMT)

Talk to us

Study Overview

On this page

Study Details

Study overview

This project allows for the systematic collection and analysis of long-term follow-up clinical parameters in children who have received a stem cell transplant. The data collected will assist in determining appropriate intervention and treatment plans for patients enrolled on this study. In addition, future patients may benefit by having the ability to anticipate problems and develop methods of prevention or early intervention.

Longitudinal Evaluation of Recipients of Hematopoietic Stem Cell Transplantation (HSCT)

Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation

Condition
Blood and Marrow Transplant (BMT)
Intervention / Treatment

-

Contacts and Locations

Stanford

Stanford University School of Medicine, Stanford, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Participant is scheduled to receive OR has received a hematopoietic stem cell transplant (HSCT) for any condition.
  • * Participant may have had a HSCT in another institution than Lucile Packard Children's Hospital (LPCH) yet has transferred follow-up long-term care to our institution and is being seen through the late-effects clinic from the Pediatric HSCT program.
  • * Participant AND/OR parent/legally authorized representative is able to provide written informed consent and assent (as applicable) for participation.
  • * Participant has relapsed from a malignant diagnosis post HSCT and is not being worked-up for a new HSCT.
  • * Participant or patient's authorized guardian is unable to provide consent and assent

Ages Eligible for Study

to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Ami Shah, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2099-01